Circulation, Vol 67, 162-171, Copyright © 1983 by American Heart Association
RE Vestal, CE Eiriksson Jr, B Musser, LK Ozaki and JB Halter
Theophylline is thought to act by inhibiting the activity of
phosphodiesterase, with a resultant increase in intracellular cyclic AMP.
However, this concept is largely based on in vitro studies using
concentrations of theophylline which greatly exceed therapeutic plasma
concentrations. To investigate the relationship of the cardiovascular and
metabolic effects of theophylline to activation of the sympathetic nervous
system, i.v. aminophylline was administered to six healthy males under
basal conditions. Each subject received four infusions. Mean theophylline
concentrations (+/- SEM) of 4.5 +/- 0.2, 10.0 +/- 0.5, 14.0 +/- 0.5 and
20.0 +/- 1.2 micrograms/ml were achieved. Plasma epinephrine increased 262%
(from 29 +/- 4 to 105 +/- 14 pg/ml, p less than 0.01) and plasma
norepinephrine increased 64% (from 190 +/- 18 to 312 +/- 51 pg/ml, p less
than 0.05) during the high-dose infusion. The increases in circulating
catecholamines were dose-related (p less than 0.001 by analysis of
variance). Dose-related increases in heart rate, systolic blood pressure,
plasma glucose, free fatty acids and insulin were also observed (p less
than 0.001 by analysis of variance). Although the duration of total
electromechanical systole (QS2) and left ventricular ejection time adjusted
for heart rate fell during the aminophylline infusions, this positive
inotropic response was not influenced by dose, except possibly the high
dose. Echocardiographic ejection fraction was not changed by the
aminophylline infusions. We conclude that the acute cardiovascular and
metabolic effects of theophylline may be mediated in part by stimulation of
the sympathetic nervous system.
ARTICLES
Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man
This article has been cited by other articles:
![]() |
T. Rieg, H. Steigele, J. Schnermann, K. Richter, H. Osswald, and V. Vallon Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 403 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takahashi, Y. Fujii, T. Hoshi, S.-i. Inomata, M. Miyabe, and H. Toyooka Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs Can J Anesth, March 1, 2000; 47(3): 265 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Loi, B. M. Parker, B. J. Cusack, and R. E. Vestal Aging and Drug Interactions. III. Individual and Combined Effects of Cimetidine and Ciprofloxacin on Theophylline Metabolism in Healthy Male and Female Nonsmokers J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 627 - 637. [Abstract] [Full Text] |
||||
![]() |
T. Minamino, M. Kitakaze, T. Morioka, K. Node, Y. Shinozaki BE, M. Chujo, H. Mori, H. Takeda, M. Inoue, M. Hori, et al. Bidirectional Effects of Aminophylline on Myocardial Ischemia Circulation, September 1, 1995; 92(5): 1254 - 1260. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |